Physicians' Academy for Cardiovascular Education

The future of HF management: How does potassium binding fit within pharmacological treatment of heart failure?

10' education - June 28, 2016 - ESC HF 2016, Florence, Italy - Kenneth Dickstein, MD - University of Bergen Stavanger University Hospital, Norway

Video navigation menu

  • The complex and increasing burden of heart failure 0:01
  • Heart failure seen from a neurohumoral perspective 2:54
  • Higher aldosterone levels in response to diuretic therapy 4:08
  • Patients with elevated serum creatinine benefit most from ramipril treatment in the HOPE trial 6:49
  • Hyperkalemia in the context of blockade of the renin-angiotensin system 7:17
  • Hyperkalemia hampers adequate guideline-indicated management of HF 13:00

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: